Personalized, non-invasive, lightweight, and portable therapeutic medical devices are an emerging development trend, finding Frost & Sullivan
Santa Clara, California., November 4, 2020 / PRNewswire / – Frost and Sullivan’s recent analysis, Phase III Medical Pipeline Analysis of Medical Devices: Potential Game Changers and Growth Enablers, Finds that the trend of technology development for pipeline therapeutic medical devices in the late stage (Phase-III) of clinical development or clinical trials is moving towards portable, lightweight and manufacture. easy to use Equipment for patients, allowing their use in home settings. The integration of therapeutic medical devices with digital technologies aims to increase patient engagement and improve treatment outcome for their disease status, especially during and after the COVID-19 epidemic.
Photo – https://mma.prnewswire.com/media/1326854/Medical_Therapeutics_Devices.jpg
For more information about this analysis, please see: http://frost.ly/4rs
“Medical medical devices can explore business opportunities in chronic diseases in oncology and neurology by delivering energy and electricity fields non-invasively to specific affected sites and eliminating systemic side effects.” Ashish kaul, Technical Insight Senior Research Analyst at Frost & Sullivan. “Going forward, advance manufacturing technology such as 3D printing can enable MediaTek companies to meet market needs in terms of urgency such as the COVID-19 epidemic or high market demand for fast manufacturing.”
Kaul said: “Medical device companies are exploring various biodegradable and recyclable plastic materials to incorporate this into their manufacturing process. Additionally, the use of biodegradable and recycled materials in home-based therapeutic medical devices will increase over the Miracle five to six years. “
The increasing permissions of medical medical devices with digital technologies such as mobile applications present immense growth potential for market participants, including:
- Non-invasive, lightweight, miniature, and portable medical devices can be developed using printed electronics components such as sensors and circuits.
- Needle-less and self-used medical devices can be developed to eliminate painful experiences during self-injection activities.
- Medical medical devices can be integrated with cloud systems, the Internet of Things (IoT), and Artificial Intelligence (AI) to analyze information gathered by devices for advanced research to understand complex diseases and develop effective treatments. And can be used.
Phase III Medical Pipeline Analysis of Medical Devices: Potential Game Changers and Growth Enablers The latest addition to Frost & Sullivan is technical Info Research and analysis are available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unexpected future.
About Frost and Sullivan
For over six decades, Frost & Sullivan has been world-renowned in helping investors, corporate leaders, and governments help with economic shifts and identify disruptive technologies, mega trends, new business models and companies, resulting in growth opportunities. There is a continuous flow. To drive future success. Contact us: start discussion.
Phase III Medical Pipeline Analysis of Medical Devices: Potential Game Changers and Growth Enablers
P: +1 210 348 10 12
I: [email protected]
Content is by PR Newswire. Tech Media is not responsible for the content provided or any link related to this content. Tech Media is not responsible for the accuracy, timeliness or quality of content.